EASL 2013 Poster 1191
1191 GS-5816, A SECOND GENERATION HCV NS5A INHIBITOR WITH POTENT ANTIVIRAL ACTIVITY, BROAD GENOTYPIC COVERAGE AND A HIGH RESISTANCE BARRIER
Cheng, G. et al.
Journal of Hepatology , Volume 58 , S484 - S485
https://www.journal-of-hepatology.eu/article/S0168-8278(13)61192-7/pdf

EASL 2017 Poster 205 

Pooled resistance analysis in HCV genotype 1â€“6-infected patients treated with glecaprevir/pibrentasvir in phase 2 and 3 clinical trials
Krishnan, P. et al.
Journal of Hepatology , Volume 66 , Issue 1 , S500

https://www.journal-of-hepatology.eu/article/S0168-8278(17)31399-5/fulltext